Jin Hongjun, Director of the Hebei Provincial Administration for Market Regulation, visited Guangxiang Pharmaceutical for a research visit.


Time:2020-05-29

【概要描述】 On the afternoon of May 27, Jin Hongjun, Director of the Hebei Provincial Administration for Market Regulation, visited Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisi Pharmaceutical Group in the Bohai New Area to conduct a research visit on work related to production safety.
 
 
On the afternoon of May 27, Jin Hongjun, Director of the Hebei Provincial Administration for Market Regulation, visited Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisi Pharmaceutical Group in the Bohai New Area to conduct a research visit on work related to production safety.
 
 
Jin Hongjun obtained detailed information from Han Shuqin, Chairwoman of Guangxiang Pharmaceutical, regarding the company’s current production, operations, and safety conditions.
Jin Hongjun said that the company’s practice of actively implementing safety production measures, strengthening awareness of safety red lines, and driving improvements in safety management levels is worthy of recognition. We must continue to attach great importance to safety production work, fulfill our responsibilities, intensify safety education and training for every employee and operator, reinforce emergency drills, and at the same time place great emphasis on equipment management, resolutely preventing any safety accidents from occurring.
Relevant officials from Cangzhou City and the Cangzhou Bohai New Area attended the research visit.
 

Keywords: